AWA Point

Interview: Will patent filers have to change practices after European Commission’s €462.6 million fine against big pharma’s Teva?

Balancing Innovation and Regulation: Comparing China’s AI Regulations with the EU AI Act

The recent passing of the EU AI Act presents an opportunity to conduct a comparative law analysis against China’s

After seven years China and EU sign investment agreement

Ai-Leen Lim considers some of the highlights from the Comprehensive Agreement on Investment between China and the EU. Agreement

All eyes on Germany as UPC is resuscitated at Bundestag and Bundesrat

German ratification of the UPCA is one of the last hurdles for the Unitary Patent system. The system has

EORI number mandatory to file actions against counterfeit goods in the EU

Danish customs oversee thousands of counterfeit goods each year and over the past five years, the number of cases

EU requires manufacturers to disclose scientific documents during risk assessment for food chain production

The European Food Safety Agency (EFSA) is in charge of the registration into the European Union of novel foods

Data Requirements for Patenting Biotech/Pharma Inventions in China and the EU

  This interactive webinar considers the filing and post-filing data requirements for biotechnology and pharmaceutical-related inventions in China and

Brands must take extra caution against counterfeits during Covid-19 pandemic

Enhanced online brand protection and anti-counterfeiting measures are needed due to the current pandemic: as demand from e-commerce consumers

Balmain case highlights risk of using specialised public with low distinctive character marks

Balmain’s appeal to the General Court demonstrates that applicants should not rely on a specialised public for goods or services

German Court finds Unified Patent Court legislation unconstitutional

Today, the court tasked with upholding Germany’s constitution, the Bundesverfassungsgericht, has issued its long-awaited decision on a complaint against